About Us

Founded in 1995, Lawley Pharmaceuticals, an Australian Perth-based privately owned company, has become a world leader in the research and development of transdermal testosterone and progesterone creams for use in men and women.

In 2020 Lawley’s past two decades of dedication and perseverance has resulted in Australian regulatory approvals that represent global breakthroughs in male and female testosterone treatment options.

Our low dose scrotal testosterone for men provides the dual benefit over existing therapies of an enhanced safety profile from third-party passive transfer at a substantially reduced cost of treatment to patients and healthcare funders.

Our female testosterone cream represents a global regulatory first for the management of hypoactive sexual desire dysfunction in postmenopausal women.

Latest News


Men. Healthier Together. Men. Healthier Together.

Bookings essential at https://www.eventbrite.com.au/e/men-healthier-together-tickets-120485129265  

The Menopause Charity launches in the UK The Menopause Charity launches in the UK

Menopause specialist Dr Louise Newson has launched a new Crowdfunding campaign for The Menopause Charity, which she hopes will change millions of women’s lives… Continue Reading →

Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1 Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1

Friday 12th June 2020 Perth, Australia and Charlotte, USA – Lawley Pharmaceuticals and Tanner Pharma Group announced today that they have initiated a global… Continue Reading →